Immuron (IMRN) Free Cash Flow (2019 - 2020)
Immuron (IMRN) recorded Free Cash Flow of -$3.25 million in FY2026 (year ended Aug 28, 2026).
Powered by 
Analysis
Immuron (IMRN) Free Cash Flow (2019 - 2020) Analysis & Trends
Starting with FY2015, Immuron's Free Cash Flow history includes 12 fiscal years.
- The FY2026 figure is the highest annual Free Cash Flow since FY2023.
- Per Business Quant data, IMRN's Free Cash Flow was -$6.14 million in FY2025, -$5.88 million in FY2024, -$2 million in FY2023 and -$2.06 million in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.06 Bn | 1,139.65 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 634.89 Bn | 553.42 Bn | 17.26 Bn | 7.30 Bn |
| 3 | AbbVie | 503.32 Bn | 476.44 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 377.44 Bn | 331.82 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 303.91 Bn | 267.90 Bn | 11.24 Bn | 5.56 Bn |
| 6 | Astrazeneca | 267.03 Bn | 240.72 Bn | 12.86 Bn | 1.01 Bn |
| 7 | Amgen | 241.88 Bn | 197.28 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 194.01 Bn | 168.20 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Immuron | 6.91 Mn | -10.23 Mn | - | - |
API Access
Immuron Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();